cholestyramine resin has been researched along with Arteriosclerosis, Coronary in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 12 (57.14) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, SS; D'Mello, M; Eikelboom, J; Paré, G; Roberts, R; Ross, S; Samani, NJ; Stewart, AF | 1 |
| Brunt, JNH; Chan, DC; Lewis, B; Pang, J; Watts, GF | 1 |
| Inazu, A; Ino, H; Kawashiri, MA; Kobayashi, J; Koizumi, J; Mabuchi, H; Nohara, A; Tada, H; Takata, M; Tsuchida, M; Yamagishi, M | 1 |
| Devendra, GP; Krasuski, RA; Whitney, EJ | 1 |
| Gylling, H; Miettinen, TA | 1 |
| Mishra, TK; Routray, S | 1 |
| Eliav, O; Leitersdorf, E; Muratti, EN; Peters, TK | 1 |
| Anderson, TJ; Frei, B; Ganz, P; Meredith, IT; Selwyn, AP; Yeung, AC | 1 |
| Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR | 1 |
| Gibson, CM; Pasternak, RC; Rosner, B; Sacks, FM; Stone, PH | 1 |
| Dudrick, SJ; Edens, RP; Goldberg, DI; Gould, KL; Hess, MJ; Latifi, R; Martucci, JP | 1 |
| Ballantyne, C; Farmer, J; Gotto, AM; Herd, JA; West, MS | 1 |
| Brunt, JN; Coltart, DJ; Lewis, B; Mandalia, S; Slavin, BM; Watts, GF | 1 |
| Barnhart, HX; Kosinski, AS; Sampson, AR | 1 |
| Fukuzawa, S; Inagaki, M; Inoue, T; Morooka, S; Ozawa, S | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Campeau, L; Forman, SA; Forrester, JS; Geller, NL; Gobel, FL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Knatterud, GL; Rosenberg, Y; Terrin, ML; White, CW | 1 |
| Brunt, JN; Coltart, DJ; Lewis, B; Lewis, ES; Mann, JI; Smith, LD; Swan, AV; Watts, GF | 1 |
| Arai, H; Hara, S; Ishii, K; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M | 1 |
| Olsson, AG | 1 |
2 review(s) available for cholestyramine resin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis.
Topics: Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholesterol, LDL; Cholestyramine Resin; Colesevelam Hydrochloride; Coronary Artery Disease; Humans; Lipoproteins; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic | 2015 |
Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosis.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Humans | 1987 |
14 trial(s) available for cholestyramine resin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
Topics: Adult; Aged; Angiography; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Data Interpretation, Statistical; Diet; Disease Progression; Humans; Hyperlipoproteinemia Type II; Incidence; Male; Middle Aged; Phenotype; Severity of Illness Index; Treatment Outcome | 2016 |
Impact of increases in high-density lipoprotein cholesterol on cardiovascular outcomes during the armed forces regression study.
Topics: Adult; Aged; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Cholestyramine Resin; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Lipoproteins, HDL; Male; Middle Aged; Niacin; Risk; Risk Factors; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
Topics: Adult; Anticholesteremic Agents; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Creatine Kinase; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Kidney; Liver; Male; Middle Aged; Patient Compliance; Placebos; Safety; Triglycerides | 1995 |
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
Topics: Acetylcholine; Anticholesteremic Agents; Antioxidants; Cholestyramine Resin; Coronary Artery Disease; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Probucol; Regression Analysis; Vasoconstriction; Vasodilation | 1995 |
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin | 1995 |
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group.
Topics: Anticholesteremic Agents; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Gemfibrozil; Humans; Lipids; Male; Middle Aged; Niacin; Pravastatin; Treatment Outcome | 1994 |
Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Artery Disease; Dietary Fats; Dipyridamole; Female; Food, Formulated; Heart; Humans; Image Processing, Computer-Assisted; Lovastatin; Male; Parenteral Nutrition, Total; Time Factors; Tomography, Emission-Computed | 1994 |
Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Artery Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins; Male; Middle Aged; Severity of Illness Index; Time Factors | 1994 |
Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS).
Topics: Analysis of Variance; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Artery Disease; Follow-Up Studies; Humans; Lipoproteins; London; Longitudinal Studies; Male; Middle Aged; Regression Analysis; Triglycerides; Ultracentrifugation | 1993 |
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Hypercholesterolemia; Life Tables; Lovastatin; Male; Middle Aged; Saphenous Vein; Treatment Outcome; Warfarin | 1997 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Topics: Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Postoperative Period; Saphenous Vein; Treatment Outcome | 2001 |
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
Topics: Angina Pectoris; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Humans; Male; Middle Aged; Remission Induction; Treatment Outcome | 1992 |
Angiographic evidence that treatment of lipoprotein abnormalities prevents progression of coronary atherosclerosis.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Humans | 1987 |
6 other study(ies) available for cholestyramine resin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
Topics: Angina Pectoris; Anticholesteremic Agents; Aortic Valve Stenosis; Blood Component Removal; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Echocardiography; Female; Heart Valve Prosthesis Implantation; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Middle Aged; Secondary Prevention | 2009 |
LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Topics: Aged; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Simvastatin; Sitosterols; Treatment Outcome | 2002 |
Current perspectives on statins.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Coronary Artery Disease; Female; Humans; India; Lovastatin; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2003 |
A regression model for multivariate random length data.
Topics: Cholestyramine Resin; Computer Simulation; Coronary Angiography; Coronary Artery Disease; Humans; Likelihood Functions; Models, Biological; Random Allocation; Regression Analysis | 1999 |
Secondary prevention with lipid lowering therapy in familial hypercholesterolemia: a correlation between new evolution of stenotic lesion and achieved cholesterol levels after revascularization procedures.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholestyramine Resin; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Probucol | 1999 |
The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
Topics: Animals; Apolipoproteins B; Cholesterol Esters; Cholestyramine Resin; Coronary Artery Disease; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; Oxidation-Reduction; Pravastatin; Probucol; Rabbits; Receptors, LDL; RNA, Messenger | 1992 |